These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32936918)

  • 1. COVID-19 and hydroxychloroquine side-effects: glucose 6-phosphate dehydrogenase deficiency (G6PD) and acute haemolytic anaemia.
    Chaney S; Basirat A; McDermott R; Keenan N; Moloney E
    QJM; 2020 Dec; 113(12):890-891. PubMed ID: 32936918
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
    Beauverd Y; Adam Y; Assouline B; Samii K
    Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic Anemia in a Glucose-6-Phosphate Dehydrogenase-Deficient Patient Receiving Hydroxychloroquine for COVID-19: A Case Report.
    Aguilar J; Averbukh Y
    Perm J; 2020; 24():. PubMed ID: 33183501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
    Maillart E; Leemans S; Van Noten H; Vandergraesen T; Mahadeb B; Salaouatchi MT; De Bels D; Clevenbergh P
    Infect Dis (Lond); 2020 Sep; 52(9):659-661. PubMed ID: 32496938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
    Palmer K; Dick J; French W; Floro L; Ford M
    Emerg Infect Dis; 2020 Sep; 26(9):2279-81. PubMed ID: 32579876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of COVID-19 in a Patient with Asymptomatic Hemoglobin D Thalassemia and Glucose-6-Phosphate Dehydrogenase Deficiency.
    Sasi S; Yassin MA; Nair AP; Al Maslamani MS
    Am J Case Rep; 2020 Jul; 21():e925788. PubMed ID: 32697769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a "humanized" G6PD A- mouse model.
    Zuchelkowski BE; Wang L; Gingras S; Xu Q; Yang M; Triulzi D; Page GP; Gordeuk VR; Kim-Shapiro DB; Lee JS; Gladwin MT
    PLoS One; 2020; 15(10):e0240266. PubMed ID: 33007039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
    Kuipers MT; van Zwieten R; Heijmans J; Rutten CE; de Heer K; Kater AP; Nur E
    Am J Hematol; 2020 Aug; 95(8):E194-E196. PubMed ID: 32390140
    [No Abstract]   [Full Text] [Related]  

  • 9. Typhoid fever and haemolytic anaemia in a black patient with glucose-6-phosphate dehydrogenase deficiency. A case report.
    Maharaj B; Jogessar VB; Leary WP; Pudifin DJ
    S Afr Med J; 1985 Jul; 68(2):110-1. PubMed ID: 4012499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
    De Franceschi L; Costa E; Dima F; Morandi M; Olivieri O
    Eur J Intern Med; 2020 Oct; 80():103. PubMed ID: 32819797
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine.
    Ibrahim H; Perl A; Smith D; Lewis T; Kon Z; Goldenberg R; Yarta K; Staniloae C; Williams M
    Clin Immunol; 2020 Oct; 219():108544. PubMed ID: 32707089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
    Onori ME; Ricciardi Tenore C; Urbani A; Minucci A
    Mol Biol Rep; 2021 Mar; 48(3):2973-2978. PubMed ID: 33620659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
    Afra TP; Nampoothiri RV; Razmi T M; Hafi NAB
    Eur J Intern Med; 2020 Oct; 80():101-102. PubMed ID: 32651040
    [No Abstract]   [Full Text] [Related]  

  • 14. Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.
    Perez J; Roustit M; Lepelley M; Revol B; Cracowski JL; Khouri C
    Ann Intern Med; 2021 Jun; 174(6):878-880. PubMed ID: 33493009
    [No Abstract]   [Full Text] [Related]  

  • 15. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of methemoglobinemia amidst the COVID-19 pandemic.
    Naymagon L; Berwick S; Kessler A; Lancman G; Gidwani U; Troy K
    Am J Hematol; 2020 Aug; 95(8):E196-E197. PubMed ID: 32413176
    [No Abstract]   [Full Text] [Related]  

  • 17. BET 2: Hydroxychloroquine in the treatment of COVID-19.
    Howard L; Baombe J; Reynard C
    Emerg Med J; 2020 Jul; 37(7):451-453. PubMed ID: 32616659
    [No Abstract]   [Full Text] [Related]  

  • 18. Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency.
    Vinzio S; Andrès E; Perrin AE; Schlienger JL; Goichot B
    Diabetes Res Clin Pract; 2004 Jun; 64(3):181-3. PubMed ID: 15126005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why G6PD Deficiency Should Be Screened Before COVID-19 Treatment With Hydroxychloroquine?
    Oymak Y; Karapinar TH; Devrim İ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):35-36. PubMed ID: 32496442
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel approach for low-dose pulmonary delivery of hydroxychloroquine in COVID-19.
    Fassihi SC; Nabar NR; Fassihi R
    Br J Pharmacol; 2020 Nov; 177(21):4997-4998. PubMed ID: 32562278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.